Current Allergy and Asthma Reports

, Volume 10, Issue 3, pp 210–214

Xenotropic Murine Leukemia Virus-Related Virus in Chronic Fatigue Syndrome and Prostate Cancer

Article

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) is a γ retrovirus that has been associated with chronic fatigue syndrome (CFS) and prostate cancer. The search for viral causes of these syndromes was reignited by the finding that RNase L activity was low in hereditary prostate cancer and some CFS patients. The six strains of XMRV that have been sequenced have greater than 99% identity, indicating a new human infection rather than laboratory contamination. DNA, RNA, and proteins from XMRV have been detected in 50% to 67% of CFS patients and in about 3.7% of healthy controls. XMRV infections could be transmitted to permissive cell lines from CFS plasma, suggesting the potential for communicable and blood-borne spread of the virus and potentially CFS. This troubling concept is currently under intense evaluation. The most important steps now are to independently confirm the initial findings; develop reliable assays of biomarkers; and to move on to investigations of XMRV pathophysiology and treatment in CFS, prostate cancer, and potentially other virus-related syndromes, if they exist.

Keywords

XMRV Xenotropic murine leukemia virus-related virus Chronic fatigue syndrome CFS Prostate cancer Gamma-retrovirus Pseudoallergy Nonallergic rhinopathy 

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Raisch KP, Pizzato M, Sun HY, et al.: Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology 2003, 308:83–91.CrossRefPubMedGoogle Scholar
  2. 2.
    •• Lombardi VC, Ruscetti FW, Das Gupta J, et al.: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326:585–589. This is the key article describing a link between XMRV and CFS.Google Scholar
  3. 3.
    Lombardi VC, Ruscetti FW, Gupta JD, et al.: Supporting online material for detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009 Oct 8 (Epub ahead of print).Google Scholar
  4. 4.
    Urisman A, Molinaro RJ, Fischer N, et al.: Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25.CrossRefPubMedGoogle Scholar
  5. 5.
    Fukuda K, Straus SE, Hickei I, et al.: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994, 121:953–959.PubMedGoogle Scholar
  6. 6.
    Kerr JR, Burke B, Petty R, et al.: Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. J Clin Pathol 2008, 61:730–739.CrossRefPubMedGoogle Scholar
  7. 7.
    Lorusso L, Mikhaylova SV, Capelli E, et al.: Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009, 8:287–291.CrossRefPubMedGoogle Scholar
  8. 8.
    Fletcher MA, Zeng XR, Barnes Z, et al.: Plasma cytokines in women with chronic fatigue syndrome. J Transl Med 2009, 7:96.CrossRefPubMedGoogle Scholar
  9. 9.
    Dong B, Silverman RH: Androgen stimulates transcription and replication of XMRV (xenotropic murine leukemia virus-related virus). J Virol 2009 Nov 11 (Epub ahead of print).Google Scholar
  10. 10.
    Schlaberg R, Choe DJ, Brown KR, et al.: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 2009, 106:16351–16356.CrossRefPubMedGoogle Scholar
  11. 11.
    Fischer N, Hellwinkel O, Schulz C, et al.: Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008, 43:277–283.CrossRefPubMedGoogle Scholar
  12. 12.
    Hohn O, Krause H, Barbarotto P, et al.: Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92.CrossRefPubMedGoogle Scholar
  13. 13.
    Nijs J, Meeus M, McGregor NR, et al.: Chronic fatigue syndrome: exercise performance related to immune dysfunction. Med Sci Sports Exerc 2005, 37:1647–1654.CrossRefPubMedGoogle Scholar
  14. 14.
    •• Coffin JM, Stoye JP: Virology. A new virus for old diseases? Science 2009, 326:530–531. Coffin brings his 40 years of experience with retroviruses to this informative editorial that introduces the findings of Lombardi et al. [2••].Google Scholar
  15. 15.
    Levy JA: Xenotropism: the elusive viral receptor finally uncovered. Proc Natl Acad Sci U S A 1999, 96:802–804.CrossRefPubMedGoogle Scholar
  16. 16.
    Battini JL, Rasko JE, Miller AD: A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci U S A 1999, 96:1385–1390.CrossRefPubMedGoogle Scholar
  17. 17.
    Hong S, Klein EA, Das Gupta J, et al.: Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 2009, 83:6995–7003.Google Scholar
  18. 18.
    Kim S, Kim N, Dong B, et al.: Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 2008, 82:9964–9977.CrossRefPubMedGoogle Scholar
  19. 19.
    Strebel K, Luban J, Jeang KT: Human cellular restriction factors that target HIV-1 replication. BMC Med 2009, 7:48.Google Scholar
  20. 20.
    CFIDS Association of America: HHS coordinating xenotropic murine leukemia virus-related virus (XMRV) scientific activities. Available at http://www.cfids.org/cfidslink/2009/120203.asp. Accessed December 15, 2009.
  21. 21.
    FightingFatigue.org: The National Cancer Institute’s interim guidelines for XMRV. Available at http://www.fightingfatigue.org/?p=7871. Accessed October 23, 2009.
  22. 22.
    Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One. 2010 Jan 6;5(1)Google Scholar
  23. 23.
    Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, Stoye JP, Bishop KN. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology. 2010 Feb 15;7(1):10.Google Scholar
  24. 24.
    •• van Kuppeveld FJ, de Jong AS, Lanke KH, Verhaegh GW, Melchers WJG, Swanink CMA, Bleijenberg G, Netea MG, Galama JMD, van der Meer JWM. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. British Medical Journal 2010 (Accessed 25 February 2010) •• No evidence of XMRV was found. The absence of XMRV infections in Europe or differences in sample handling may contribute to the negative finding.Google Scholar
  25. 25.
    •• Voisset C, Weiss RA, Griffiths DJ: Human RNA “rumor” viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev 2008, 72:157–196. This is a cautionary tale of the inference of retroviruses in human disease and the difficulties of proving cause and effect. Will XMRV become another rumor, or be conformed as causing human disease? Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Georgetown UniversityWashingtonUSA

Personalised recommendations